Afinum, SHS sell Evitria to trade

Afinum and SHS Capital have sold their stakes in Switzerland-based diagnostic and therapeutic antibodies specialist Evitria toSweden-based Atlas Antibodies in a deal that values Evitria atmore than EUR 200m.